Jul 28 |
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
|
Jul 24 |
Compass Pathways to announce second quarter financial results on August 1, 2024
|
Jul 23 |
Compass a new outperform at RBC on optimism for psychedelic-based therapies
|
Jul 8 |
Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies
|
Jul 2 |
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
|
Jun 26 |
Compass Pathways appoints Lori Englebert as Chief Commercial Officer
|
Jun 24 |
Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
Jun 12 |
Should You Buy the Dip on Compass Pathways Stock?
|
Jun 10 |
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
|
Jun 9 |
After FDA setback, psychedelic drugmakers distance themselves from a pioneer
|